Showing 1 - 4 results of 4 for search 'Mariana Castanheira', query time: 0.01s Refine Results
  1. 1
    Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales

    Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against... by Helio S. Sader, John H. Kimbrough, Rodrigo E. Mendes, Mariana Castanheira

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Characterization of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i> Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospitals and Activity of Aztreonam–Avibactam and Comparator Agents (2019–2023)

    Characterization of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i> Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospital... by Helio S. Sader, Timothy B. Doyle, John H. Kimbrough, Rodrigo E. Mendes, Mariana Castanheira

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019–2023)

    Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019–2023) by Helio S. Sader, John H. Kimbrough, Marisa L. Winkler, Rodrigo E. Mendes, Mariana Castanheira

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    In vitro activity of omadacycline against bacterial isolates from bone/joint infections and rare pathogens in the SENTRY antimicrobial surveillance program (2015–2023)

    In vitro activity of omadacycline against bacterial isolates from bone/joint infections and rare pathogens in the SENTRY antimicrobial surveillance program (2015–2023) by Michael D. Huband, Paul R. Rhomberg, Kelley A. Fedler, Christopher Blankers, Diane Anastasiou, Alisa W. Serio, Mariana Castanheira

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: